106 related articles for article (PubMed ID: 12642324)
21. A comparative study of the efficacy of 2.5% phenylephrine and 10% phenylephrine in pre-operative mydriasis for routine cataract surgery.
Symons RC; Walland MJ; Kaufman DV
Eye (Lond); 1997; 11 ( Pt 6)():946-8. PubMed ID: 9537165
[No Abstract] [Full Text] [Related]
22. Pupil dilation with intracameral lidocaine during phacoemulsification.
Jayadev C; Nayak BK
J Cataract Refract Surg; 2007 Sep; 33(9):1503; author reply 1503. PubMed ID: 17720056
[No Abstract] [Full Text] [Related]
23. The short to medium-term risks of intracameral phenylephrine.
Williams GS; Radwan M; Kadare S; Williams CP
Middle East Afr J Ophthalmol; 2012 Oct; 19(4):357-60. PubMed ID: 23248535
[TBL] [Abstract][Full Text] [Related]
24. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studies.
Hovanesian JA; Sheppard JD; Trattler WB; Gayton JL; Malhotra RP; Schaaf DT; Ng E; Dunn SH
J Cataract Refract Surg; 2015 Oct; 41(10):2060-8. PubMed ID: 26703280
[TBL] [Abstract][Full Text] [Related]
25. Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective.
Davey K; Chang B; Purslow C; Clay E; Vataire AL
BMC Ophthalmol; 2018 Apr; 18(1):104. PubMed ID: 29673317
[TBL] [Abstract][Full Text] [Related]
26. Author reply: To PMID 22709418.
Lorente R; de Rojas V; Vázquez de Parga P; Moreno C; Varela J; Landaluce ML; Méndez J; Lorente B
Ophthalmology; 2013 Jul; 120(7):e43-4. PubMed ID: 23823516
[No Abstract] [Full Text] [Related]
27. Alpha-1 adrenergic agonists for the prevention of floppy iris syndrome.
Carifi G; Kopsachilis N
Ophthalmology; 2013 Jul; 120(7):e43. PubMed ID: 23823517
[No Abstract] [Full Text] [Related]
28. Posterior chamber injection of intracameral mydriatics increases the durability of the mydriatic response.
Lundqvist O; Behndig A
Acta Ophthalmol; 2013 Nov; 91(7):657-9. PubMed ID: 22963348
[TBL] [Abstract][Full Text] [Related]
29. [Perioperative circulatory side effects of topical 5% phenylephrine for mydriasis].
Hempel S; Senn P; Pakdaman F; Schmid MK; Suppiger M; Schipper I
Klin Monbl Augenheilkd; 1999 Nov; 215(5):298-304. PubMed ID: 10609245
[TBL] [Abstract][Full Text] [Related]
30. Topical phenylephrine in laser in situ keratomileusis.
Issa AF
J Cataract Refract Surg; 2007 Feb; 33(2):355-6. PubMed ID: 17276291
[No Abstract] [Full Text] [Related]
31. A comparison of blood pressure changes in phacoemulsification surgery with topical and retrobulbar block local anesthesia: part II.
Suzuki R; Kawata K; Kuroki S; Fujiwara N; Iwamoto M
Ophthalmologica; 1997; 211(6):327-31. PubMed ID: 9380347
[TBL] [Abstract][Full Text] [Related]
32. Ocular and systemic effects of topical instillation of different formulations of phenylephrine in rabbits.
Cioli V; Durando L; Luparini MR; Ciarniello MG
Boll Chim Farm; 1988 Apr; 127(4):80-2. PubMed ID: 3233162
[No Abstract] [Full Text] [Related]
33. Ropivacaine versus lidocaine for deep-topical, nerve-block anaesthesia in cataract surgery: a double-blind randomized clinical trial.
Ugur B; Dundar SO; Ogurlu M; Gezer E; Ozcura F; Gursoy F
Clin Exp Ophthalmol; 2007 Mar; 35(2):148-51. PubMed ID: 17362456
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary edema following instillation of topical phenylephrine eyedrops in a child under general anesthesia.
Venkatakrishnan J; Jagadeesh V; Kannan R
Eur J Ophthalmol; 2011; 21(1):115-7. PubMed ID: 20677168
[TBL] [Abstract][Full Text] [Related]
35. [Intracameral lidocaine and phacoemulsification under topical anesthesia. Apropos of 80 operations].
Roux L; Rigal-Sastourné JC; Bidaux F; May F; Renard JP; Maurin JF
J Fr Ophtalmol; 1998 Apr; 21(4):257-63. PubMed ID: 9759414
[TBL] [Abstract][Full Text] [Related]
36. Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution.
Dreno C; Gicquel T; Harry M; Tribut O; Aubin F; Brandhonneur N; Dollo G
Ann Pharm Fr; 2015 Jan; 73(1):31-6. PubMed ID: 25577014
[TBL] [Abstract][Full Text] [Related]
37. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
Motta MM; Coblentz J; Fernandes BF; Burnier MN
Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
[TBL] [Abstract][Full Text] [Related]
38. [Biochemical stress monitoring during cataract surgery; phenylephrine 10% shows no changes in serum-catecholamines in comparison with phenylephrine 5%].
Schlichtenbrede FC; Burkhardt KU; Bartram MC; Wiedemann R
Klin Monbl Augenheilkd; 2001 Jul; 218(7):479-83. PubMed ID: 11512247
[TBL] [Abstract][Full Text] [Related]
39. 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides.
Suwan-Apichon O; Ratanapakorn T; Panjaphongse R; Sinawat S; Sanguansak T; Yospaiboon Y
J Med Assoc Thai; 2010 Apr; 93(4):467-73. PubMed ID: 20462091
[TBL] [Abstract][Full Text] [Related]
40. Assessing the accuracy of intracameral phenylephrine preparation in cataract surgery.
Guthrie S; Jensen T; Hartley RC; Ramaesh K; Lockington D
Eye (Lond); 2018 Oct; 32(10):1615-1620. PubMed ID: 29907787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
